OpportunityTitle: Reduction of Hemolysis in Specimens from Patients in Emergency Departments: Evaluation of Laboratory Medicine Best Practices and Recommendations
AdditionalInformationOnEligibility: Selected applicant eligibility is in compliance with applicant eligibility authorized under statuatory authority Public Health Service Act, Section 317(k)(2), 42 U.S.C 247b(k)(2), and the Catalog of Federal Domestic Assistance (CFDA) number 93.064.  Applicants must have experience in the administration and evaluation of standardized quality assurance programs in multiple, diverse laboratory sites (including community hospitals and academic medical centers) as specified in CFDA 93.064.
Description: The purpose of the project is to evaluate the clinical laboratory best practice recommendations for reducing blood sample hemolysis rates developed through the Laboratory Medicine Best PracticesTM (LMBPTM) Initiative of the Centers for Disease Control and Prevention. These recommendations were the product of a systematic review for evidence of effectiveness for practices to reduce hemolysis and were developed using the A6 Method established through the LMBPTM Initiative. The project seeks to measure the extent of improvement that results from implementation of these evidence-based best practice recommendations. The project can be implemented as a study conducted in multiple institutions or facilities in a healthcare system. The purpose is limited to quality improvement associated with delivering healthcare, and the associated measuring and reporting of performance data.
GrantorContactEmailDescription: Grants Policy
GrantorContactText: Paramjit Sandhu&lt;br/&gt;hkx9@cdc.gov&lt;br/&gt;
CloseDateExplanation: Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.